Intellia Therapeutics NTLA Increase Decrease In Operating Lease Liabilities
Increase Decrease In Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept ntla:IncreaseDecreaseInOperatingLeaseLiabilities.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's increase decrease in operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's increase decrease in operating lease liabilities?
- Intellia Therapeutics (NTLA) reported increase decrease in operating lease liabilities of -$12.84M in Q1 2026.
- How has Intellia Therapeutics's increase decrease in operating lease liabilities changed year-over-year?
- Intellia Therapeutics's increase decrease in operating lease liabilities increased by 55.8% year-over-year, from -$29.03M to -$12.84M.
- What is the long-term trend for Intellia Therapeutics's increase decrease in operating lease liabilities?
- Over 4 years (2021 to 2025), Intellia Therapeutics's increase decrease in operating lease liabilities has grown at a 56.7% compound annual growth rate (CAGR), from -$9.11M to -$54.95M.
- What does increase decrease in operating lease liabilities mean?
- This represents the net change in the present value of future lease payments for operating leases. It reflects the cash impact of lease payments made versus the recognition of new lease obligations. This metric is vital for assessing the company's ongoing financial obligations and the scale of its leased infrastructure.